These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37925055)

  • 1. Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
    Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
    Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
    Grabenstetter A; Mohanty AS; Rana S; Zehir A; Brannon AR; D'Alfonso TM; DeLair DF; Tan LK; Ross DS
    Hum Pathol; 2020 Aug; 102():44-53. PubMed ID: 32599083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of metastatic histologic special types of invasive breast cancer.
    Pareja F; Ferrando L; Lee SSK; Beca F; Selenica P; Brown DN; Farmanbar A; Da Cruz Paula A; Vahdatinia M; Zhang H; Zoppoli G; Wen HY; Brogi E; Robson ME; Razavi P; Chandarlapaty S; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2020; 6():53. PubMed ID: 33083532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
    Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity.
    Soong TR; Dillon DA; Rice-Stitt TL; Wieczorek TJ; Baker GM; Darvishian F; Collins LC; Lester SC; Schnitt SJ; Harrison BT
    Mod Pathol; 2022 Oct; 35(10):1370-1382. PubMed ID: 35477749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
    Arps DP; Healy P; Zhao L; Kleer CG; Pang JC
    Breast Cancer Res Treat; 2013 Apr; 138(3):719-26. PubMed ID: 23535842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
    Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
    J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
    Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
    Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
    J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
    Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
    Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
    Soslow RA; Carlson DL; Horenstein MG; Osborne MP
    Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.
    Pérez-Mies B; Caniego-Casas T; Carretero-Barrio I; Biscuola M; López-García MA; Hardisson D; Rosas M; López Rodríguez MJ; Cristóbal E; Pizarro D; Rosa-Rosa JM; Palacios J
    Am J Surg Pathol; 2022 Nov; 46(11):1545-1553. PubMed ID: 35877198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
    Ross JS; Wang K; Sheehan CE; Boguniewicz AB; Otto G; Downing SR; Sun J; He J; Curran JA; Ali S; Yelensky R; Lipson D; Palmer G; Miller VA; Stephens PJ
    Clin Cancer Res; 2013 May; 19(10):2668-76. PubMed ID: 23575477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.
    González-Martínez S; Kajabova VH; Pérez-Mies B; Carretero-Barrio I; Caniego-Casas T; Sarrió D; Moreno-Bueno G; Gión M; Perez-García J; Cortés J; Smolkova B; Palacios J
    Virchows Arch; 2024 Aug; 485(2):291-297. PubMed ID: 38713384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.
    Elangovan A; Hooda J; Savariau L; Puthanmadhomnarayanan S; Yates ME; Chen J; Brown DD; McAuliffe PF; Oesterreich S; Atkinson JM; Lee AV
    Mol Cancer Res; 2022 Sep; 20(9):1405-1419. PubMed ID: 35665642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
    Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV
    Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.
    Zhang Y; Luo X; Chen M; Yang L; Lei T; Pu T; Wei B; Bu H; Zhang Z
    Breast Cancer Res Treat; 2022 Jul; 194(2):279-295. PubMed ID: 35666367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.